Jilin Jian Yisheng Pharmaceutical Co., Ltd. (SHE:002566)
China flag China · Delayed Price · Currency is CNY
6.11
-0.03 (-0.49%)
Nov 6, 2026, 11:05 AM CST

SHE:002566 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
26.112952.0994.7383.196.02
Depreciation & Amortization
42.742.747.0848.9344.2743.09
Other Amortization
0.680.680.631.530.921.18
Loss (Gain) From Sale of Assets
-0.4-0.4-0.29-0.78--
Asset Writedown & Restructuring Costs
0.30.30.270.240.270.28
Loss (Gain) From Sale of Investments
-9.53-9.53-11.98-4.02-2.62-0.25
Provision & Write-off of Bad Debts
2.132.13-0.23-1.27-0.46
Other Operating Activities
7.6615.614.2610.8819.9922.41
Change in Accounts Receivable
-29.65-29.655.2175.22-17.02-31.92
Change in Inventory
43.0343.03-11.33-12.65-4.9917.85
Change in Accounts Payable
8.018.01-37.26-7.0918.5464.21
Operating Cash Flow
87.9198.7458.94209.13145.86215.1
Operating Cash Flow Growth
48.21%67.51%-71.81%43.38%-32.19%5.69%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-2.61-13.64-15.94-35.77-41.36-107.07
Sale of Property, Plant & Equipment
-0.320.280.450.74-0
Investment in Securities
-70.01-51.76-365-4040-100
Other Investing Activities
13.8611.715.291.643.13-
Investing Cash Flow
-59.08-53.42-375.21-73.391.77-207.06

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
-20--430397.45
Long-Term Debt Issued
-333600520--
Total Debt Issued
335353600520430397.45
Short-Term Debt Repaid
-----400-415
Long-Term Debt Repaid
--360.64-638.35-484.84-3.06-5.75
Lease Payments
-5.64-5.64-8.25-4.84-3.06-5.75
Total Debt Repaid
-340.74-360.64-638.35-484.84-403.06-420.75
Net Debt Issued (Repaid)
-5.74-7.64-38.3535.1626.94-23.3
Common Dividends Paid
-38.37-45.61-61.64-29.86--23.32
Other Financing Activities
-1.57--3.43-50.99-28.72
Financing Cash Flow
-45.68-53.25-99.998.73-24.06-75.34

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
00-0---
Net Cash Flow
-16.84-7.93-416.25144.47123.57-67.3

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
85.3185.143173.36104.49108.04
Free Cash Flow Growth
84.83%97.89%-75.19%65.91%-3.28%-15.32%
Free Cash Flow Margin
14.23%13.29%6.43%20.31%12.59%12.31%
Free Cash Flow Per Share
0.260.260.130.520.320.33
Levered Free Cash Flow
82.3554.519.6594.7277.275.5
Unlevered Free Cash Flow
84.0462.418.3103.2686.0413.85
Free Cash Flow After Leases
79.6679.4634.75168.52101.43102.29

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
89.4189.7796.65113.44100.2698.63
Change in Working Capital
18.2618.26-42.8757.63-1.3452.82